Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 11,945,130 shares, an increase of 4.9% from the November 30th total of 11,390,423 shares. Currently, 13.0% of the company’s stock are short sold. Based on an average daily volume of 620,336 shares, the days-to-cover ratio is presently 19.3 days.

Shares of Corindus Vascular Robotics (CVRS) opened at $1.01 on Friday. The stock has a market cap of $188.65, a PE ratio of -4.21 and a beta of 19.51. Corindus Vascular Robotics has a 1-year low of $0.40 and a 1-year high of $2.25.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.01. The firm had revenue of $2.43 million for the quarter, compared to the consensus estimate of $3.60 million. Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. boosted its holdings in shares of Corindus Vascular Robotics by 147.8% during the 2nd quarter. Goldman Sachs Group Inc. now owns 58,824 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 35,086 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Corindus Vascular Robotics by 67.6% in the second quarter. Rhumbline Advisers now owns 80,868 shares of the medical equipment provider’s stock worth $150,000 after buying an additional 32,608 shares during the last quarter. New York State Common Retirement Fund boosted its holdings in shares of Corindus Vascular Robotics by 334.6% in the second quarter. New York State Common Retirement Fund now owns 89,100 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 68,599 shares during the last quarter. California State Teachers Retirement System boosted its holdings in shares of Corindus Vascular Robotics by 34.4% in the second quarter. California State Teachers Retirement System now owns 148,558 shares of the medical equipment provider’s stock worth $276,000 after buying an additional 38,000 shares during the last quarter. Finally, Teachers Advisors LLC boosted its holdings in shares of Corindus Vascular Robotics by 184.7% in the second quarter. Teachers Advisors LLC now owns 167,633 shares of the medical equipment provider’s stock worth $312,000 after buying an additional 108,745 shares during the last quarter.

CVRS has been the subject of a number of analyst reports. BidaskClub lowered shares of Corindus Vascular Robotics from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 11th. Zacks Investment Research upgraded shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research note on Monday, November 13th. Finally, ValuEngine lowered shares of Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Two research analysts have rated the stock with a sell rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $2.33.

WARNING: “Corindus Vascular Robotics Inc (CVRS) Short Interest Update” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/30/corindus-vascular-robotics-inc-cvrs-short-interest-update.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.